Double maintains 2 strategies that include KYMR - Kymera Therapeutics, Inc.
Current Value
$44.571 Year Return
Current Value
$44.571 Year Return
Yahoo
Kymera Therapeutics, Inc. (NASDAQ:KYMR) is one of the 11 Best Mid-cap Healthcare Stocks to Buy According to Hedge Funds. Morgan Stanley analyst Judah Frommer assumed coverage of the company’s stock with an “Overweight” rating and a price objective of $70, down from $79. The research firm mentioned that the company is developing oral small-molecule approaches to […]
Yahoo
There’s no doubt about it: the stock market’s strong performance over the past few months is fueling an optimistic mood. Driving this renewed optimism are several tailwinds – falling inflation, expectations for Fed rate cuts later this year, President Trump’s decisive (and brief) intervention in the ongoing Middle East war, and the steady decline in oil prices have all combined to support stocks and push sentiment higher. Against this backdrop, Morgan Stanley’s Mike Wilson has been watching the
Yahoo
NovoCure (NVCR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Yahoo
Gilead Sciences Inc. (NASDAQ:GILD) is one of the undervalued S&P 500 stocks to buy according to hedge funds. On June 25, Gilead Sciences expanded its oncology pipeline through an exclusive agreement with Kymera Therapeutics Inc. (NASDAQ:KYMR). This deal is potentially valued at up to $750 million and focuses on advancing Kymera’s innovative molecular glue degrader/MGD […]
Yahoo
Investing.com -- Kymera Therapeutics’ growing roster of partnerships continues to reinforce its long-term value, according to Oppenheimer, despite a setback in one of its programs.
Yahoo
WATERTOWN, Mass., June 26, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, today announced the pricing of its underwritten public offering of $250.8 million of shares of its common stock and, in lieu of common stock to certain investors, pre-funded warrants to purchase shares of its common stock. Kymera is selling 5,044,500 shares of common sto
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| MMIT | 0.03% | $1.03B | 0.3% |
| GSST | 0.06% | $920.88M | 0.16% |
| XBIL | 0.06% | $784.60M | 0.15% |
| ITM | 0.10% | $1.87B | 0.18% |
| IBTP | -0.12% | $142.98M | 0.07% |
| IBMS | 0.17% | $89.61M | 0.18% |
| BUXX | -0.18% | $312.40M | 0.25% |
| JPLD | 0.23% | $2.06B | 0.24% |
| HYMB | 0.23% | $2.62B | 0.35% |
| BSV | -0.24% | $37.89B | 0.03% |
| TAXF | 0.25% | $477.91M | 0.29% |
| GOVT | 0.42% | $27.25B | 0.05% |
| SHM | -0.44% | $3.41B | 0.2% |
| BIL | -0.44% | $41.93B | 0.1356% |
| TFI | 0.50% | $3.21B | 0.23% |
| SHYD | -0.53% | $331.91M | 0.35% |
| MEAR | -0.55% | $1.14B | 0.25% |
| NYF | -0.56% | $884.52M | 0.25% |
| FLMI | 0.58% | $735.37M | 0.3% |
| PZA | -0.69% | $2.83B | 0.28% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| BTAL | -41.95% | $315.93M | 1.43% |
| VIXY | -40.34% | $184.73M | 0.85% |
| TAIL | -39.39% | $94.86M | 0.59% |
| IVOL | -20.73% | $342.69M | 1.02% |
| XONE | -12.92% | $628.85M | 0.03% |
| SHYM | -12.24% | $355.86M | 0.35% |
| DFNM | -10.04% | $1.58B | 0.17% |
| TBLL | -9.83% | $2.12B | 0.08% |
| SPTS | -9.82% | $5.77B | 0.03% |
| BILS | -9.58% | $3.80B | 0.1356% |
| USDU | -9.56% | $129.80M | 0.5% |
| UTWO | -9.48% | $376.33M | 0.15% |
| SCHO | -9.05% | $10.98B | 0.03% |
| CLIP | -8.91% | $1.55B | 0.07% |
| UUP | -8.67% | $196.45M | 0.77% |
| AGZ | -8.00% | $609.66M | 0.2% |
| BSMW | -7.37% | $107.49M | 0.18% |
| CTA | -7.31% | $1.08B | 0.76% |
| ULST | -7.21% | $592.38M | 0.2% |
| VGSH | -7.12% | $22.68B | 0.03% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| XBI | 64.63% | $4.81B | 0.35% |
| GNOM | 61.01% | $46.47M | 0.5% |
| IBB | 58.21% | $5.37B | 0.45% |
| ARKG | 57.83% | $1.03B | 0.75% |
| IWO | 55.15% | $11.77B | 0.24% |
| PBE | 53.57% | $226.91M | 0.58% |
| IWC | 53.48% | $840.86M | 0.6% |
| IWM | 52.78% | $65.64B | 0.19% |
| VTWO | 52.58% | $12.65B | 0.07% |
| PTH | 52.25% | $96.25M | 0.6% |
| SCHA | 51.45% | $17.61B | 0.04% |
| ISCG | 51.41% | $688.57M | 0.06% |
| PINK | 51.27% | $130.30M | 0.5% |
| KJAN | 51.22% | $279.50M | 0.79% |
| VBK | 51.19% | $19.19B | 0.07% |
| XPH | 51.00% | $150.58M | 0.35% |
| ESML | 50.44% | $1.88B | 0.17% |
| SMMD | 50.34% | $1.49B | 0.15% |
| QQQJ | 50.28% | $625.39M | 0.15% |
| KJUL | 50.19% | $159.39M | 0.79% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| NRIX | 67.22% | $965.91M | -42.49% | 0.00% |
| VERA | 65.17% | $1.55B | -35.19% | 0.00% |
| BPMC | 55.85% | $8.36B | +9.80% | 0.00% |
| CGON | 54.05% | $2.07B | -21.33% | 0.00% |
| IDYA | 53.05% | $2.00B | -42.45% | 0.00% |
| VYGR | 52.90% | $196.44M | -60.29% | 0.00% |
| DNLI | 52.50% | $2.23B | -33.52% | 0.00% |
| RGNX | 52.07% | $456.52M | -28.72% | 0.00% |
| BNTX | 51.12% | $27.39B | +34.50% | 0.00% |
| CRNX | 50.76% | $3.00B | -39.42% | 0.00% |
| VTYX | 49.76% | $202.10M | +14.98% | 0.00% |
| RNA | 49.03% | $3.79B | -28.98% | 0.00% |
| IMNM | 49.00% | $778.76M | -31.05% | 0.00% |
| NUVL | 48.94% | $5.89B | +5.23% | 0.00% |
| XENE | 48.78% | $2.53B | -19.91% | 0.00% |
| RVMD | 48.37% | $7.17B | -11.19% | 0.00% |
| BEAM | 48.19% | $2.22B | -14.88% | 0.00% |
| ROIV | 48.02% | $7.87B | +2.94% | 0.00% |
| KURA | 47.96% | $550.62M | -71.03% | 0.00% |
| XNCR | 47.86% | $660.47M | -52.14% | 0.00% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| CBOE | -13.68% | $24.55B | +38.09% | 1.08% |
| ED | -10.16% | $36.42B | +10.51% | 3.36% |
| KMB | -7.61% | $43.78B | -6.43% | 3.77% |
| CIG.C | -7.44% | $2.68B | +23.72% | 0.00% |
| LITB | -7.20% | $24.26M | -71.62% | 0.00% |
| K | -6.51% | $27.64B | +40.17% | 2.86% |
| EXC | -5.99% | $44.05B | +23.53% | 3.60% |
| SAIC | -5.62% | $5.45B | -0.05% | 1.30% |
| ZCMD | -4.66% | $28.54M | -8.87% | 0.00% |
| CME | -4.56% | $99.17B | +44.04% | 1.75% |
| AQB | -4.32% | $3.04M | -56.34% | 0.00% |
| VSTA | -4.11% | $325.62M | +30.97% | 0.00% |
| CL | -4.01% | $73.44B | -7.30% | 2.25% |
| AIFU | -3.99% | $17.40M | +87.81% | 0.00% |
| VSA | -3.80% | $8.59M | -17.17% | 0.00% |
| AMT | -3.42% | $103.46B | +6.67% | 3.01% |
| MO | -3.40% | $98.62B | +24.36% | 7.00% |
| DUK | -3.35% | $91.85B | +13.12% | 3.57% |
| AEP | -3.12% | $56.65B | +16.73% | 3.49% |
| MCK | -2.93% | $89.25B | +24.22% | 0.40% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| CNK | -0.02% | $3.43B | +38.45% | 0.53% |
| EZPW | -0.16% | $760.29M | +36.43% | 0.00% |
| DAO | -0.18% | $275.90M | +140.33% | 0.00% |
| T | 0.21% | $198.74B | +46.45% | 5.06% |
| GO | 0.26% | $1.26B | -39.10% | 0.00% |
| HSY | 0.29% | $33.36B | -11.86% | 3.35% |
| BTCT | 0.34% | $28.19M | +79.43% | 0.00% |
| DFDV | 0.39% | $363.21M | +2,422.23% | 0.00% |
| CPSH | 0.41% | $36.02M | +47.62% | 0.00% |
| ACI | -0.44% | $12.57B | +13.79% | 2.42% |
| COR | -0.45% | $57.63B | +33.93% | 0.73% |
| PRMB | 0.49% | $11.49B | +48.80% | 1.26% |
| DG | -0.69% | $24.71B | -14.69% | 2.10% |
| OXBR | 0.82% | $16.75M | -10.00% | 0.00% |
| BJ | -0.82% | $14.09B | +17.71% | 0.00% |
| CYCN | -0.86% | $11.40M | +5.03% | 0.00% |
| CNC | -0.91% | $16.18B | -51.64% | 0.00% |
| NEUE | -0.94% | $60.71M | +34.39% | 0.00% |
| GIS | 0.96% | $27.86B | -18.70% | 5.88% |
| MSIF | -1.25% | $773.71M | +36.92% | 7.56% |
